Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes -- Ignore unavailable to you. Want to Upgrade?

To: Starduster who wrote (4603)	4/5/1998 11:32:00 PM
From: CYBERKEN	Read Replies (1) \| Respond to of 34592

For anyone doing DD on breast cancer investments: Include Ligand in your research (LGND). Prospects for co-lead drug Targretin in breast cancer are very high. Company also has possibly best pipeline in biotech, impressive management, lucrative deals w/big pharmas. I don't hold any right now-looking for a dip in next few months (and needed more $$ for RNTK), but I consider it a terrific LONG-TERM play for anyone interested in biotech stocks. Check out the SI thread as well as Henry Niman's web site. Web site will shorten your DD time considerably.